CD19 and metastatic melanoma: Other highly malignant tumors such as metastatic melanoma (SOX-10 marker) and lymphoma (CD-19, PAX-5, terminal deoxynucleotidyl transferase (TdT) markers, etc.)should also be considered in differentials [9,10].